Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP247292.RAoQM5Nh_Q6pkekgYLL97H9-wSB0BbMCLTIDkowt-p26Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP247292.RAoQM5Nh_Q6pkekgYLL97H9-wSB0BbMCLTIDkowt-p26Y130_assertion type Assertion NP247292.RAoQM5Nh_Q6pkekgYLL97H9-wSB0BbMCLTIDkowt-p26Y130_head.
- NP247292.RAoQM5Nh_Q6pkekgYLL97H9-wSB0BbMCLTIDkowt-p26Y130_assertion description "[We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247292.RAoQM5Nh_Q6pkekgYLL97H9-wSB0BbMCLTIDkowt-p26Y130_provenance.
- NP247292.RAoQM5Nh_Q6pkekgYLL97H9-wSB0BbMCLTIDkowt-p26Y130_assertion evidence source_evidence_literature NP247292.RAoQM5Nh_Q6pkekgYLL97H9-wSB0BbMCLTIDkowt-p26Y130_provenance.
- NP247292.RAoQM5Nh_Q6pkekgYLL97H9-wSB0BbMCLTIDkowt-p26Y130_assertion SIO_000772 10071127 NP247292.RAoQM5Nh_Q6pkekgYLL97H9-wSB0BbMCLTIDkowt-p26Y130_provenance.
- NP247292.RAoQM5Nh_Q6pkekgYLL97H9-wSB0BbMCLTIDkowt-p26Y130_assertion wasDerivedFrom befree-2016 NP247292.RAoQM5Nh_Q6pkekgYLL97H9-wSB0BbMCLTIDkowt-p26Y130_provenance.
- NP247292.RAoQM5Nh_Q6pkekgYLL97H9-wSB0BbMCLTIDkowt-p26Y130_assertion wasGeneratedBy ECO_0000203 NP247292.RAoQM5Nh_Q6pkekgYLL97H9-wSB0BbMCLTIDkowt-p26Y130_provenance.